aldehyde dehydrogenase 2 family member |
0.42 (0.29–0.6) |
.00 |
BCL2 antagonist/killer 1 |
1.88 (1.26–2.8) |
.00 |
solute carrier family 27 member 5 |
0.52 (0.36–0.74) |
.00 |
BEN domain containing 3 |
1.94 (1.34–2.82) |
.00 |
isovaleryl-CoA dehydrogenase |
0.47 (0.32–0.68) |
.00 |
RAD9-HUS1-RAD1 interacting nuclear orphan 1 |
1.81 (1.28–2.57) |
.00 |
phosphoenolpyruvate carboxykinase 2, mitochondrial |
0.54 (0.38– 0.77) |
.00 |
TOPBP1 interacting checkpoint and replication regulator |
1.95 (1.38–2.77) |
.00 |
acyl-CoA synthetase medium chain family member 2A |
0.5 (0.35–0.71) |
.00 |
suppressor APC domain containing 2 |
2.17 (1.52–3.09) |
.00 |
tetratricopeptide repeat domain 36 |
0.48 (0.32– 0.7) |
.00 |
caspase 2 |
1.89 (1.32–2.7) |
.00 |
lactate dehydrogenase D |
0.55 (0.38–0.8) |
.00 |
cell division cycle associated 4 |
2.07 (1.31–3.28) |
.00 |
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase |
0.61 (0.42 –0.87) |
.01 |
cyclin dependent kinase 16 |
2.16 (1.53–3.06) |
.00 |
glycine-N-acyltransferase like 1 |
0.47 (0.32–0.7) |
.00 |
centromere protein A |
2.33 (1.65–3.29) |
.00 |
phosphatidylethanolamine binding protein 1 |
0.55 (0.38– 0.79) |
.00 |
centrosomal protein 55 |
2.62 (1.83–3.75) |
.00 |
4-aminobutyrate aminotransferase |
0.49 (0.34–0.69) |
.00 |
CCR4-NOT transcription complex subunit 6 |
2.2 (1.52–3.17) |
.00 |
hydroxysteroid 17-beta dehydrogenase 6 |
0.48 (0.34–0.69) |
.00 |
DEP domain containing 1B |
2.14 (1.4–3.28) |
.00 |
alcohol dehydrogenase 1B (class I), beta polypeptide |
0.57 (0.4–0.81) |
.00 |
glucose-6-phosphate dehydrogenase |
2.52 (1.77–3.59) |
.00 |
methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1 |
0.63 (0.45–0.89) |
.01 |
GIT ArfGAP 1 |
1.98 (1.38–2.84) |
.00 |
glycine-N-acyltransferase like 1 |
0.58 (0.39–0.86) |
.01 |
glucosamine-6-phosphate deaminase 1 |
2.19 (1.54–3.13) |
.00 |
cytochrome b5 type A |
0.55 (0.38–0.8) |
.00 |
G2 and S-phase expressed 1 |
2 (1.41–2.85) |
.00 |
SEC14 like lipid binding 2 |
0.5 (0.35–0.71) |
.00 |
inhibitor of nuclear factor kappa B kinase subunit epsilon |
1.78 (1.16–2.72) |
.01 |
acyl-CoA synthetase medium chain family member 2B |
0.51 (0.35–0.74) |
.00 |
interleukin enhancer binding factor 3 |
1.55 (1.07–2.24) |
.02 |
dicarbonyl and L-xylulose reductase |
0.58 (0.4– 0.84) |
.00 |
kinesin family member 23 |
1.92 (1.36–2.71) |
.00 |
hydroxyacid oxidase 1 |
0.48 (0.32–0.73) |
.00 |
kinesin family member 2C |
2.4 (1.66–3.46) |
.00 |
dimethylglycine dehydrogenase |
0.47 (0.33–0.67) |
.00 |
La ribonucleoprotein 4B |
1.84 (1.25–2.71) |
.00 |
cytochrome P450 family 4 subfamily F member 2 |
0.56 (0.38–0.82) |
.00 |
ceramide synthase 5 |
1.81 (1.2–2.72) |
.00 |
coagulation factor XI |
0.45 (0.31–0.65) |
.00 |
LIM domain kinase 1 |
1.9 (1.34–2.69) |
.00 |
glyoxylate and hydroxypyruvate reductase |
0.55 (0.38–0.78) |
.00 |
lamin B2 |
1.77 (1.23–2.56) |
.00 |
alpha-2-glycoprotein 1, zinc-binding |
0.61 (0.43–0.86) |
.00 |
microtubule associated protein RP/EB family member 1 |
1.6 (1.12–2.29) |
.01 |
cytochrome P450 family 8 subfamily B member 1 |
0.6 (0.42–0.85) |
.00 |
mediator complex subunit 22 |
2.15 (1.51–3.07) |
.00 |
aspartate dehydrogenase domain containing |
0.47 (0.31–0.73) |
.00 |
major facilitator superfamily domain containing 10 |
1.63 (1.16–2.3) |
.00 |
hydroxyacylglutathione hydrolase |
0.45 (0.32–0.63) |
.00 |
myelin protein zero like 1 |
2.03 (1.37–2.99) |
.00 |
acetyl-CoA acetyltransferase 1 |
0.41 (0.29–0.59) |
.00 |
myotubularin related protein 2 |
2.39 (1.69–3.38) |
.00 |
malonyl-CoA decarboxylase |
0.66 (0.45–0.95) |
.03 |
MYB proto-oncogene like 2 |
2.29 (1.62–3.24) |
.00 |
enoyl-CoA hydratase domain containing 2 |
0.52 (0.37–0.74) |
.00 |
NDRG family member 3 |
1.83 (1.28–2.6) |
.00 |
sulfite oxidase |
0.45 (0.31–0.64) |
.00 |
phosphodiesterase 7A |
1.53 (1.08–2.16) |
.02 |
cell death inducing DFFA like effector b |
0.56 (0.39–0.79) |
.00 |
phosphatidylinositol glycan anchor biosynthesis class S |
1.71 (1.21–2.41) |
.00 |
catalase |
0.44 (0.3–0.65) |
.00 |
pyruvate kinase M2 |
2.07 (1.45–2.95) |
.00 |
tyrosine aminotransferase |
0.49 (0.35–0.7) |
.00 |
pleckstrin homology and RhoGEF domain containing G2 |
1.33 (0.94–1.88) |
.11 |
ATP binding cassette subfamily C member 6 |
0.45 (0.31–0.65) |
.00 |
plexin A1 |
1.98 (1.4–2.8) |
.00 |
cysteine dioxygenase type 1 |
0.51 (0.36–0.72) |
.00 |
PNMA family member 1 |
1.93 (1.36–2.72) |
.00 |
carboxypeptidase N subunit 2 |
0.53 (0.38–0.76) |
.00 |
regulator of chromosome condensation 2 |
2.22 (1.54–3.19) |
.00 |
complement C8 alpha chain |
0.59 (0.42–0.83) |
.00 |
ring finger protein 24 |
2 (1.42–2.84) |
.00 |
carboxylesterase 2 |
0.7 (0.48–1.02) |
.06 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
1.63 (1.13–2.35) |
.01 |
glutaryl-CoA dehydrogenase |
0.48 (0.34–0.67) |
.00 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 |
2.22 (1.53–3.22) |
.00 |
sterol carrier protein 2 |
0.51 (0.36–0.73) |
.00 |
SMYD family member 5 |
2.01 (1.41–2.86) |
.00 |
retinol binding protein 4 |
0.35 (0.25–0.5) |
.00 |
spermatogenesis associated serine rich 2 |
2.39 (1.68–3.39) |
.00 |
retinol binding protein 4 |
0.65 (0.46–0.91) |
.01 |
syntaxin 6 |
1.91 (1.34–2.73) |
.00 |
solute carrier family 10 member 1 |
0.46 (0.32–0.66) |
.00 |
transcription factor 3 |
1.56 (1.1–2.21) |
.01 |
methionine adenosyltransferase 1A |
0.59 (0.42–0.83) |
.00 |
TPD52 like 2 |
1.98 (1.4–2.8) |
.00 |
aquaporin 9 |
0.52 (0.36–0.75) |
.00 |
tripartite motif containing 59 |
1.64 (1.15–2.33) |
.01 |
apolipoprotein C4 |
0.52 (0.36–0.75) |
.00 |
TYRO3 protein tyrosine kinase |
1.88 (1.28–2.76) |
.00 |
speedy/RINGO cell cycle regulator family member C |
0.52 (0.36–0.75) |
.00 |
VPS37C subunit of ESCRT-I |
1.61 (1.14–2.28) |
.01 |
selenium binding protein 1 |
0.6 (0.42–0.85) |
.00 |
YEATS domain containing 2 |
2.23 (1.56–3.21) |
.00 |